COVID-19

News

Novavax's COVID-19 shot effective against UK strain

Novavax’s COVID-19 vaccine could be added to the UK’s growing arsenal of shots against the disease after it showed 89.3% efficacy in a late-stage trial.

Views & Analysis

COVID drives a customer experience shift in life sciences CR...

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, acc

News

The unprecedented challenge of pricing a coronavirus vaccine

EMA approves AZ’s COVID-19 vaccine – including for over-65s

The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18, despite assertions in Germany this week that it shouldn’t be used in elderly people.

Partner Content

Partner Content

RxSource optimizes clinical labeling process with PRISYM 360...

How PRISYM 360 streamlined RxSource's labeling

Partner Content

Partner Content

Unpacking rare diseases in the first edition of Delta magazi...

Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases.

Partner Content

pexels-gustavo-fring-3985170-pharmaphorum

Partner Content

Mistrust in medical research: a patient perspective

In medical research, trust has traditionally been hard-fought for. Terms like “lab rats” and “guinea pigs” are often used in conversations about clinical trials.

Novavax's COVID-19 shot effective against UK strain

COVID drives a customer experience shift in life sciences CR...

EMA approves AZ’s COVID-19 vaccine – including for over-65s

RxSource optimizes clinical labeling process with PRISYM 360...

Unpacking rare diseases in the first edition of Delta magazi...

Mistrust in medical research: a patient perspective

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks